Vafseo Tablet, Film Coated
Product Images NDC 59922-643

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Vafseo (NDC 59922-643). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akebia Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Vafseo Figure 01)

FDA Label Image

Figure 1 (Vafseo Figure 02)

Figure 1 (Vafseo Figure 02)
This is not-readable.*
FDA Label Image

Figure 2 (Vafseo Figure 03)

Figure 2 (Vafseo Figure 03)
This text provides information on various HMG Co-A Reductase Inhibitors (Statins) such as Atorvastatin, Pravastatin, Rosuvastatin, and Simvastatin. It also mentions their metabolites and substrates for different transporters and enzymes like OAT1, OAT3, CYP2C9, and P-gp. The text further discusses the impact of Vadadustat on the pharmacokinetics of other drugs. Additionally, it includes terms like AUC, Cmax, and Geometric Mean Ratio (30%Cl) for evaluating changes relative to the reference values.*
FDA Label Image

Carton Label (Vafseo Figure 04)

FDA Label Image

60 Count Bottle Label (Vafseo Figure 05)

FDA Label Image

Carton Label (Vafseo Figure 06)

FDA Label Image

60 Count Bottle Label (Vafseo Figure 07)

60 Count Bottle Label (Vafseo Figure 07)
This text contains instructions related to a prescription medication, likely called Vadadustat, in tablet form. The recommended dosage and storage conditions are provided, stating that the tablets should be swallowed whole and stored at a temperature between 20°C to 25°C (68°F to 77°F). The tablets should not be cut, crushed, or chewed. Additionally, the text indicates that the medication is manufactured for Akebia Therapeutics, Inc. in Cambridge, MA. It also mentions including a Medication Guide.*
FDA Label Image

Carton Label (Vafseo Figure 08)

FDA Label Image

60 Count Bottle Label (Vafseo Figure 09)

60 Count Bottle Label (Vafseo Figure 09)
This text provides information about a medication with the NDC code 59922-643-60. It includes instructions to swallow the tablets whole and store them at a temperature range of 20°C to 25°C. The medication is manufactured for Akebia Therapeutics, Inc. located in Cambridge, MA. The text also indicates that the product is from Spain. Make sure to refer to the prescribing information and the medication guide for proper dosage and usage details.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.